Hacker News new | ask | show | jobs
by notlob 2904 days ago
One biotech person's perspective is that these are changes in the right direction. Things were certainly not perfect in the pre-AIA era, but post-AIA and recent court decisions have had many negative impacts on our industry, particularly diagnostics and particularly new ventures. The uncertainty associated with an “issued” patent has decimated their value, to the loss of innovation in our industry.
1 comments

I hope you get down voted not for taking a contrarian position but just because your comment does barely support the argument. Maybe anecdotes would help to illustrate your point?
I wasn’t intending to advance an argument, merely present that as a biotech entrepreneur in the process of forming a new company I for one like many of the changes in this proposal. I completely get why software people take umbrage with patents, but wanted to politely put forward that it isn’t a universal feeling.
> I completely get why software people take umbrage with patents, but wanted to politely put forward that it isn’t a universal feeling.

The obvious solution would be to not have software patents, but this bill seems to be proposing the exact opposite of that.